Financial Contrast: Taysha Gene Therapies (NASDAQ:TSHA) versus AIM ImmunoTech (NYSE:AIM)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation. Valuation and Earnings This table compares […]
More Stories
StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)
StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Thursday. The firm...
Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Thursday. The firm...
RLI (NYSE:RLI) Shares Scheduled to Split on Thursday, January 16th
Shares of RLI Corp. (NYSE:RLI – Free Report) are set to split on Thursday, January 16th. The 2-1 split was...
Martin Marietta Materials (NYSE:MLM) Rating Increased to Hold at StockNews.com
StockNews.com upgraded shares of Martin Marietta Materials (NYSE:MLM – Free Report) from a sell rating to a hold rating in...
Landmark Bancorp (NASDAQ:LARK) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Landmark Bancorp (NASDAQ:LARK – Free Report) in a research note released on Thursday. The...
Tripadvisor (NASDAQ:TRIP) Downgraded by StockNews.com to Hold
StockNews.com cut shares of Tripadvisor (NASDAQ:TRIP – Free Report) from a buy rating to a hold rating in a research...